Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
Silvana Leit, C. E. Masse(Unknown), Samantha Carriero, Rosanna Kapeller, Mark E. Cartwright, Salma B. Rafi(Schrodinger (United States)), Nicholas A. Boyles(Schrodinger (United States)), Alan Collis, Heather Blanchette, William Westlin(Brigham and Women's Hospital), Angela V. Toms, Scott D. Edmondson(Unknown), Jignesh B. Timaniya(Piramal (India)), Mark A. Ashwell(Arqule (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Phani Ghanakota(Schrodinger (United States)), Vinayak Hosagrahara, Jeremy R. Greenwood(Schrodinger (United States)), Shulu Feng(Schrodinger (United States)), Sayan Mondal(Heidelberg University), Geraldine Harriman, Donna L. Romero(Xerox (France)), Bhaskar Srivastava, P. Tarantino, Wenyan Miao(Millennium Engineering and Integration (United States)), Ronald T. Wester, Joshua McElwee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Neelu Kaila, Robert Abel(Schrodinger (United States))
Cited by 60
Related Papers
Comparison of multiple Amber force fields and development of improved protein backbone parameters
|Proteins Structure Function and Bioinformatics|2006|7.1k
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
|Journal of Chemical Theory and Computation|2015|3.1k
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space
|Journal of Chemical Theory and Computation|2021|1.9k